Rethinking Breach Notices. HHS Withdraws Final Rule for More Consideration
Modern healthcare 2010 Aug 2; 40(31): 8-9
Showing items related by title, author, creator and subject.
Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products and Draft Guidances and Two Guidances for Industry on the Content and Format of Labeling for Human Prescription Drug and Biological Products; Final Rule and Notices Unknown author (United States. Food and Drug Administration [FDA], 2006-01-24)